Table 2 Type of thrombotic event and antithrombotic therapy at the time of event
Type of TE | Total n (%) | On VKA n (%) | On LMWH n (%) | On LDA n (%) | No AC n (%) |
|---|---|---|---|---|---|
All TE | 32 (100.0%) | 14 (45.2%) | 4 (12.9%) | 7 (22.6%) | 8 (25.8%) |
Venous TE | 16 (50.0%) | 8 (53.3%) | 3 (20.0%) | 3 (20.0%) | 3 (20.0%) |
Lower extremity DVT | 6 (18.8%) | 4 (66.7%) | 0 (0.0%) | 0 (0.0%) | 2 (33.3%) |
Isolated PE | 6 (18.8%) | 2 (40.0%) | 1 (20.0%) | 2 (40.0%) | 1 (20.0%) |
Lower extremity DVT + PE | 1 (3.1%) | 1 (100.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
Upper extremity DVT | 1 (3.1%) | 0 (0.0%) | 1 (100.0%) | 1 (100.0%) | 0 (0.0%) |
Renal vein thrombosis | 1 (3.1%) | 0 (0.0%) | 1 (100.0%) | 0 (0.0%) | 0 (0.0%) |
Ocular vein thrombosis | 1 (3.1%) | 1 (100.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
Arterial TE | 16 (50.0%) | 6 (37.5%) | 1 (6.3%) | 4 (25.0%) | 5 (31.3%) |
Stroke | 8 (25.0%) | 3 (37.5%) | 0 (0.0%) | 1 (12.5%) | 3 (37.5%) |
TIA | 1 (3.1%) | 1 (100.0%) | 0 (0.0%) | 1 (100.0%) | 0 (0.0%) |
Myocardial infarction | 5 (15.6%) | 1 (20.0%) | 1 (20.0%) | 1 (20.0%) | 2 (40.0%) |
Peripheral artery TE | 2 (6.3%) | 1 (50.0%) | 0 (0.0%) | 1 (50.0%) | 0 (0.0%) |